These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 2896134)

  • 1. Beta-endorphin and islet hormone release in type-2 diabetes mellitus the effects of normoglycemia, enkephalin, naloxone and somatostatin.
    Giugliano D; Cozzolino D; Salvatore T; Ceriello A; Giunta R; Torella R; D'Onofrio F
    Diabete Metab; 1987; 13(6):618-24. PubMed ID: 2896134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-endorphin infusion restores acute insulin responses to glucose in type-2 diabetes mellitus.
    Giugliano D; Ceriello A; Salvatore T; Paolisso G; D'Onofrio F; Lefèbvre P
    J Clin Endocrinol Metab; 1987 May; 64(5):944-8. PubMed ID: 2951394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-endorphin inhibits insulin secretion from isolated pancreatic islets.
    Schleicher RL
    Endocrinology; 1989 Mar; 124(3):1254-8. PubMed ID: 2521821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-endorphin-induced inhibition and stimulation of insulin secretion in normal humans is glucose dependent.
    Giugliano D; Cozzolino D; Salvatore T; Torella R; D'Onofrio F
    Diabetes; 1988 Sep; 37(9):1265-70. PubMed ID: 2970411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered metabolic and hormonal responses to epinephrine and beta-endorphin in human obesity.
    Giugliano D; Cozzolino D; Salvatore T; Torella R; Franchimont P; D'Onofrio F; Lefebvre PJ
    J Clin Endocrinol Metab; 1988 Aug; 67(2):238-44. PubMed ID: 2969000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-endorphin and islet hormone release in humans: evidence for interference with cAMP.
    Giugliano D; Cozzolino D; Ceriello A; Salvatore T; Paolisso G; Torella R
    Am J Physiol; 1989 Sep; 257(3 Pt 1):E361-6. PubMed ID: 2551176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of beta-endorphin, met-enkephalin, and dynorphin A on basal and stimulated insulin secretion in the mouse.
    Ahrén B
    Int J Pancreatol; 1989 Sep; 5(2):165-78. PubMed ID: 2574736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperglycemia and obesity as determinants of glucose, insulin, and glucagon responses to beta-endorphin in human diabetes mellitus.
    Giugliano D; Salvatore T; Cozzolino D; Ceriello A; Torella R; D'Onofrio F
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1122-8. PubMed ID: 2952663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity to beta-endorphin as a cause of human obesity.
    Giugliano D; Salvatore T; Cozzolino D; Ceriello A; Torella R; D'Onofrio F
    Metabolism; 1987 Oct; 36(10):974-8. PubMed ID: 2958673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-endorphin and the endocrine pancreas. Studies in healthy and diabetic human beings.
    Feldman M; Kiser RS; Unger RH; Li CH
    N Engl J Med; 1983 Feb; 308(7):349-53. PubMed ID: 6296674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of opiate-receptor blockade on normoglycemic and hypoglycemic glucoregulation.
    el-Tayeb KM; Brubaker PL; Lickley HL; Cook E; Vranic M
    Am J Physiol; 1986 Mar; 250(3 Pt 1):E236-42. PubMed ID: 3006509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiological elevations of plasma beta-endorphin alter glucose metabolism in obese, but not normal-weight, subjects.
    Giugliano D; Cozzolino D; Salvatore T; Ceriello A; Torella R; Franchimont P; Lefebvre PJ; D'Onofrio F
    Metabolism; 1992 Feb; 41(2):184-90. PubMed ID: 1736041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradoxical reduction in pancreatic glucagon with normalization of somatostatin and decrease in insulin in normoglycemic alloxan-diabetic dogs: a putative mechanism of glucagon irresponsiveness to hypoglycemia.
    Rastogi KS; Lickley L; Jokay M; Efendic S; Vranic M
    Endocrinology; 1990 Feb; 126(2):1096-104. PubMed ID: 1967577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid peptide effects on insulin release and c-AMP in islets of Langerhans.
    Green IC; Ray K; Perrin D
    Horm Metab Res; 1983 Mar; 15(3):124-8. PubMed ID: 6133828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual action of beta-endorphin on insulin release in genetically obese and lean mice.
    Khawaja XZ; Green IC
    Peptides; 1991; 12(2):227-33. PubMed ID: 2067974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta endorphin modulation of the glucoregulatory effects of repeated epinephrine infusion in alloxan-diabetic and normal dogs.
    el-Tayeb KM; Vranic M; Brubaker PL; Lickley HL
    Diabetologia; 1987 Sep; 30(9):745-54. PubMed ID: 2962893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infusion of graded concentrations of somatostatin in man: pharmacokinetics and differential inhibitory effects on pituitary and islet hormones.
    Skamene A; Patel YC
    Clin Endocrinol (Oxf); 1984 May; 20(5):555-64. PubMed ID: 6146413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of met-enkephalin and naloxone on somatostatin and insulin secretion from the isolated, perfused rat pancreas.
    Di Scala-Guénot D; McIntosh CH
    Diabetes; 1985 Dec; 34(12):1283-7. PubMed ID: 2866128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-endorphin stimulates the secretion of insulin and glucagon in diabetes mellitus.
    Reid RL; Sandler JA; Yen SS
    Metabolism; 1984 Mar; 33(3):197-9. PubMed ID: 6319955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of naloxone on pancreatic and gastric endocrine function in response to carbohydrate and fat-rich test meals.
    Schusdziarra V; Holland A; Maier V; Pfeiffer EF
    Peptides; 1984; 5(1):65-71. PubMed ID: 6143305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.